newsfilter
← Latest News
GlobeNewswire·

ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference

Cambridge, Massachusetts, Dec. 01, 2025 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (NASDAQ:PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other